A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes
Autor: | Hollander, Priscilla, Cooper, John, Bregnhøj, Jesper, Pedersen, Claus Bang |
---|---|
Zdroj: | In Clinical Therapeutics November 2008 30(11):1976-1987 |
Databáze: | ScienceDirect |
Externí odkaz: |